Deavers MT - Search Results

1

EphA2 overexpression is associated with angiogenesis in ovarian cancer.

Lin YG, Han LY, Kamat AA, Merritt WM, Landen CN, Deavers MT, Fletcher MS, Urbauer DL, Kinch MS, Sood AK. Lin YG, et al. Among authors: deavers mt. Cancer. 2007 Jan 15;109(2):332-40. doi: 10.1002/cncr.22415. Cancer. 2007. PMID: 17154180 Free article.

2

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

3

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.

Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Hu W, et al. Clin Exp Metastasis. 2000;18(1):83-8. doi: 10.1023/a:1026596609969. Clin Exp Metastasis. 2000. PMID: 11206843

4

The expression of decorin in human ovarian tumors.

Nash MA, Deavers MT, Freedman RS. Nash MA, et al. Among authors: deavers mt. Clin Cancer Res. 2002 Jun;8(6):1754-60. Clin Cancer Res. 2002. PMID: 12060613

5

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

Verschraegen CF, Hu W, Du Y, Mendoza J, Early J, Deavers M, Freedman RS, Bast RC Jr, Kudelka AP, Kavanagh JJ, Giovanella BC. Verschraegen CF, et al. Clin Cancer Res. 2003 Feb;9(2):845-52. Clin Cancer Res. 2003. PMID: 12576458

6

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Among authors: deavers mt. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

7

Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast RC Jr, Gershenson DM, Schmandt R. Shvartsman HS, et al. Among authors: deavers mt. Gynecol Oncol. 2003 Jul;90(1):44-50. doi: 10.1016/s0090-8258(03)00257-9. Gynecol Oncol. 2003. PMID: 12821340

8

Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma.

Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CF. Le DT, et al. Cancer Invest. 2003;21(5):682-9. doi: 10.1081/cnv-120023766. Cancer Invest. 2003. PMID: 14628425 Clinical Trial.

9

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

10

Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.

Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MT. Tangjitgamol S, et al. Among authors: deavers mt. Int J Gynecol Cancer. 2005 Jul-Aug;15(4):646-56. doi: 10.1111/j.1525-1438.2005.00121.x. Int J Gynecol Cancer. 2005. PMID: 16014119 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page